title: [Beta-blocker in secondary prevention of cardiovascular disease].
abstract: Since the 1970s beta-blockers are being increasingly used in the treatment of cardiovascular diseases. Many randomized trials have shown a better prognosis of patients under beta-blockade suffering from arterial hypertension and heart failure, after myocardial infarction and left ventricular dysfunction, respectively. Therefore, beta-blockers are an essential part in the treatment of cardiovascular disease.
authors.affiliation: Kardiologische Gemeinschaftspraxis, Duisburg-Zentrum, Friedrich-Wilhelm-Strasse 80, 47051 Duisburg, Germany. gsauer@cardiologie-duisburg.de
authors.forename: G
authors.initials: G
authors.lastname: Sauer
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy*
chemical_list: D000319:Adrenergic beta-Antagonists